Data as of Apr 17
| -0.01 / -0.16%|
The 2 analysts offering 12-month price forecasts for Sinovac Biotech Ltd have a median target of 8.00, with a high estimate of 9.00 and a low estimate of 7.00. The median estimate represents a +30.72% increase from the last price of 6.12.
The current consensus among 2 polled investment analysts is to Buy stock in Sinovac Biotech Ltd. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.